REG - Rentokil Initial PLC - Issuance of $500 million 4.625% Notes due 2031

Rentokil InitialAnnouncement

23/04/2026 14:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260423:nRSW7139Ba&default-theme=true

RNS Number : 7139B  Rentokil Initial PLC  23 April 2026

 

 

 

23 April 2026

RENTOKIL INITIAL PLC

ISSUANCE OF $500 MILLION 4.625% NOTES DUE 2031

On 23 April 2026, Rentokil Terminix Funding plc, a wholly-owned finance
subsidiary of Rentokil Initial plc (the "Company"), issued senior, unsecured
$500 million 4.625% Notes due 2031 (the "Notes") guaranteed by the Company and
offered in the United States only to qualified institutional buyers pursuant
to Rule 144A under the U.S. Securities Act of 1933, as amended (the
"Securities Act") and outside the United States pursuant to Regulation S under
the Securities Act. The Company intends to use the net proceeds from the Notes
issuance for general corporate purposes, including debt repayment.

Application has been made to list the Notes on the Official List of the Irish
Stock Exchange plc trading as Euronext Dublin ("Euronext Dublin") and to trade
the Notes on the Global Exchange Market of Euronext Dublin.

Enquiries:

Investors / Analysts: Heather Wood, Rentokil Initial plc, +44 7808 098793

Media: Malcolm Padley, Rentokil Initial plc, +44 7788 978199

 

About Rentokil Initial plc:

 

Rentokil Initial plc is a global leader in Pest Control and Hygiene &
Wellbeing services. It employs c.63,400 people in 90 countries.

 

www.rentokil-initial.com (https://www.rentokil-initial.com/)

DISCLAIMER

The information contained herein shall not constitute or form part of any
offer to sell or solicitation of an offer to buy the securities referred to
herein. The Notes have not been and will not be registered under the
Securities Act, or any state securities laws and, unless so registered, may
not be offered or sold within the United States or to, or for the account or
the benefit of, US persons, as defined in Regulation S under the Securities
Act, except pursuant to an exemption from or in a transaction not subject to
the registration requirements of the Securities Act and in compliance with any
applicable state securities laws.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IODBXGDSDDDDGLX



            Copyright 2019 Regulatory News Service, all rights reserved